Evidence map›Paper›PMID 32574338›Full record

ArticleFrontiers in medicine2020

The Rise and Impact of COVID-19 in India.

S Udhaya Kumar, D Thirumal Kumar, B Prabhu Christopher, C George Priya Doss

Abstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A Review of the Machine Learning Algorithms for Covid-19 Case Analysis.IEEE transactions on artificial intelligence · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Dialogues in health · 2022
    Article
  12. Wise investment is needed for maximising the benefits in Covid times.Journal of family medicine and primary care · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. A cross-sectional study of COVID-19 outbreak in Indian population.Annals of medicine and surgery (2012) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S Udhaya KumarSchool of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
D Thirumal KumarSchool of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
B Prabhu ChristopherVIT-BS, Vellore Institute of Technology, Vellore, India.
C George Priya DossSchool of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease (COVID-19) pandemic, which originated in the city of Wuhan, China, has quickly spread to various countries, with many cases having been reported worldwide. As of May 8th, 2020, in India, 56,342 positive cases have been reported. India, with a population of more than 1.34 billion-the second largest population in the world-will have difficulty in controlling the transmission of severe acute respiratory syndrome coronavirus 2 among its population. Multiple strategies would be highly necessary to handle the current outbreak; these include computational modeling, statistical tools, and quantitative analyses to control the spread as well as the rapid development of a new treatment. The Ministry of Health and Family Welfare of India has raised awareness about the recent outbreak and has taken necessary actions to control the spread of COVID-19. The central and state governments are taking several measures and formulating several wartime protocols to achieve this goal. Moreover, the Indian government implemented a 55-days lockdown throughout the country that started on March 25th, 2020, to reduce the transmission of the virus. This outbreak is inextricably linked to the economy of the nation, as it has dramatically impeded industrial sectors because people worldwide are currently cautious about engaging in business in the affected regions.

Indexed as

COVID-19economyIndiasafety measuresSARS-CoV-2

Identifiers

PMID32574338
PMCPMC7256162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.